AU7249491A - Improved immunogenic compositions - Google Patents

Improved immunogenic compositions

Info

Publication number
AU7249491A
AU7249491A AU72494/91A AU7249491A AU7249491A AU 7249491 A AU7249491 A AU 7249491A AU 72494/91 A AU72494/91 A AU 72494/91A AU 7249491 A AU7249491 A AU 7249491A AU 7249491 A AU7249491 A AU 7249491A
Authority
AU
Australia
Prior art keywords
immunogenic compositions
improved immunogenic
improved
compositions
immunogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72494/91A
Other languages
English (en)
Inventor
Andrew Malcolm
Paul Messner
Wolfgang Mundt
Uwe B. Sleytr
Richard H. Smith Jr.
Frank M Unger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alberta Research Council
Original Assignee
Chembiomed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/487,729 external-priority patent/US5043158A/en
Application filed by Chembiomed Ltd filed Critical Chembiomed Ltd
Publication of AU7249491A publication Critical patent/AU7249491A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6068Other bacterial proteins, e.g. OMP

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU72494/91A 1990-03-02 1991-03-04 Improved immunogenic compositions Abandoned AU7249491A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/487,729 US5043158A (en) 1987-08-21 1990-03-02 Immunogenic compositions containing ordered carriers
US487729 1990-03-02

Publications (1)

Publication Number Publication Date
AU7249491A true AU7249491A (en) 1991-09-18

Family

ID=23936884

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72494/91A Abandoned AU7249491A (en) 1990-03-02 1991-03-04 Improved immunogenic compositions

Country Status (5)

Country Link
EP (1) EP0517743A1 (ja)
JP (1) JPH05505181A (ja)
AU (1) AU7249491A (ja)
CA (1) CA2077352A1 (ja)
WO (1) WO1991012819A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9400650D0 (en) * 1994-01-14 1994-03-09 Smithkline Beecham Biolog Expression of surface lazer proteins
WO2006063592A1 (en) * 2004-12-14 2006-06-22 Alk Abelló A/S Pharmaceutical composition comprising a bacterial cell displaying a heterologous proteinaceous compound
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3727987A1 (de) * 1987-08-21 1989-03-02 Sleytr Uwe B Pharmazeutische struktur

Also Published As

Publication number Publication date
WO1991012819A1 (en) 1991-09-05
CA2077352A1 (en) 1991-09-03
JPH05505181A (ja) 1993-08-05
EP0517743A1 (en) 1992-12-16

Similar Documents

Publication Publication Date Title
AU649084B2 (en) Anticalculus oral compositions
AU7227491A (en) Mouthrinse composition
AU8554691A (en) Improved formulations
AU6997891A (en) Improved shotcrete compositions
AU8907391A (en) Cleansing compositions
AU8600291A (en) Cosmetic composition
AU5939394A (en) Sustained release compositions
AU2963192A (en) Fullerene-polymer compositions
AU8647791A (en) Natural deodorant compositions
AU8021191A (en) Cosmetic composition
AU7086891A (en) Cosmetic composition
AU7713991A (en) Tgf-beta compositions
AU645847B2 (en) Organosilicon compositions
AU7362591A (en) Polymer compositions
AU1013992A (en) Lice-repellant compositions
AU8130391A (en) Solid formulations
AU9018791A (en) Rheometer
GB9001694D0 (en) Immunogenic compositions
AU2960892A (en) Immunogen composition
AU648841B2 (en) Cosmetic composition
AU5117790A (en) Improved clear organosiloxane compositions
AU7420191A (en) Insecticidal compositions
AU8127591A (en) Cosmetic composition
AU7928191A (en) Compositions
AU1164892A (en) Compositions